Get the Stockscreener App
19.88
1.53%
0.30
After Hours:
19.88
Adma Biologics Inc stock is traded at $19.88, with a volume of 1.46M.
It is up +1.53% in the last 24 hours and up +15.72% over the past month.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
See More
Previous Close:
$19.58
Open:
$19.58
24h Volume:
1.46M
Relative Volume:
0.43
Market Cap:
$4.73B
Revenue:
$474.17M
Net Income/Loss:
$208.93M
P/E Ratio:
23.41
EPS:
0.8493
Net Cash Flow:
$65.61M
1W Performance:
+0.76%
1M Performance:
+15.72%
6M Performance:
+12.06%
1Y Performance:
+14.25%
1-Day Range:
$19.53
$19.94
1-Week Range:
$18.33
$19.94
52-Week Range:
$13.76
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Name
Adma Biologics Inc
Sector
Industry
Phone
(201) 478-5552
Address
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
19.88 | 4.66B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.31 | 115.75B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
779.36 | 80.71B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
407.73 | 52.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
852.04 | 52.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.76 | 37.29B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-23 | Resumed | Raymond James | Strong Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Nov-11-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-09-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-19 | Initiated | Jefferies | Buy |
| Apr-15-19 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-19 | Resumed | H.C. Wainwright | Buy |
| Dec-11-17 | Reiterated | Maxim Group | Buy |
| Nov-14-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-23-17 | Upgrade | Maxim Group | Hold → Buy |
| Aug-01-16 | Downgrade | Maxim Group | Buy → Hold |
| Jul-25-16 | Reiterated | Maxim Group | Buy |
| May-13-15 | Reiterated | Maxim Group | Buy |
| Dec-08-14 | Initiated | Oppenheimer | Outperform |
| Dec-01-14 | Reiterated | Maxim Group | Buy |
View All
Adma Biologics Inc Stock (ADMA) Latest News
ADMA Biologics Inc $ADMA Shares Bought by Voya Investment Management LLC - MarketBeat
Texas Permanent School Fund Corp Has $1.87 Million Holdings in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics (ADMA): Firm Updates 2025 Revenue Guidance - Finviz
Should You Be Adding ADMA Biologics (NASDAQ:ADMA) To Your Watchlist Today? - Yahoo Finance
How ADMA Biologics Inc. stock valuations compare to rivalsJuly 2025 Breakouts & Verified Swing Trading Watchlists - Улправда
Fed Meeting: Will ADMA Biologics Inc. stock outperform growth indexes2025 Pullback Review & Long-Term Growth Stock Strategies - Улправда
Published on: 2025-12-21 05:20:22 - Улправда
Perpetual Ltd Cuts Stake in ADMA Biologics Inc $ADMA - MarketBeat
Jobs Data: How ADMA Biologics Inc. stock valuations compare to rivalsPortfolio Gains Report & Advanced Technical Analysis Signals - Улправда
Will ADMA Biologics Inc. stock gain from lower inflationJuly 2025 Reactions & Risk Controlled Stock Pick Alerts - DonanımHaber
Published on: 2025-12-19 13:57:53 - Улправда
Decliners Report: Can ADMA Biologics Inc. stock sustain free cash flow growth2025 Winners & Losers & Low Risk High Reward Ideas - DonanımHaber
Can ADMA Biologics Inc. stock sustain revenue growthWeekly Loss Report & Low Volatility Stock Suggestions - Улправда
What analyst consensus says on ADMA Biologics Inc. stock2025 Valuation Update & Fast Gaining Stock Reports - Улправда
CEO Grossman Sells 21,000 ($415.6K) Of Adma Biologics Inc [ADMA] - TradingView — Track All Markets
ADMA Biologics (ADMA) CEO trades stock under Rule 10b5-1 plan - Stock Titan
Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year? - MSN
Thrivent Financial for Lutherans Raises Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Does ADMA’s Upgraded EPS Outlook And Higher-Yield Manufacturing Change The Bull Case For ADMA Biologics (ADMA)? - Sahm
ADMA Biologics Inc $ADMA Shares Purchased by Ranger Investment Management L.P. - MarketBeat
Cim LLC Acquires New Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Precision Trading with Adma Biologics Inc (ADMA) Risk Zones - news.stocktradersdaily.com
ADMA Biologics Inc $ADMA Holdings Decreased by AWM Investment Company Inc. - MarketBeat
The Play On ADMA Biologics: A Discounted Stock With Good Prospects (NASDAQ:ADMA) - Seeking Alpha
Here's Why Adma Biologics (ADMA) Fell More Than Broader Market - MSN
Is ADMA Biologics (ADMA) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Osterweis Capital Management Inc. Takes $5.40 Million Position in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc $ADMA Shares Purchased by Marathon Capital Management - MarketBeat
Federated Hermes Inc. Has $17.06 Million Stake in ADMA Biologics Inc $ADMA - MarketBeat
Arrowstreet Capital Limited Partnership Cuts Stake in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics (ADMA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Ophir Asset Management Pty Ltd Boosts Position in ADMA Biologics Inc $ADMA - MarketBeat
Ardsley Advisory Partners LP Has $7.28 Million Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat
WINTON GROUP Ltd Has $4.97 Million Stock Position in ADMA Biologics Inc $ADMA - MarketBeat
Will ASCENIV Momentum and FDA-Cleared Yield Gains Change ADMA Biologics' (ADMA) Narrative? - Sahm
Is ADMA Biologics Inc a good long term investmentLong-Term Growth Stocks & You’ve Never Seen Stock Picks Like These - earlytimes.in
What analysts say about ProShares Trust ProShares Ultra Financials stockHigh Yield Income Stocks & Small Investment Capital Gains - earlytimes.in
Adma Biologics (ADMA) Up 43.3% Since Last Earnings Report: Can It Continue? - sharewise.com
Stonepine Capital Management LLC Sells 60,000 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Are Options Traders Betting on a Big Move in ADMA Biologics Stock? - MSN
Technical Reactions to ADMA Trends in Macro Strategies - news.stocktradersdaily.com
Rhumbline Advisers Buys 30,391 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Looks Just Right With A 25% Price Jump - simplywall.st
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet - sharewise.com
Legal & General Group Plc Acquires 37,699 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Northwest & Ethical Investments L.P. Has $425,000 Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Elo Mutual Pension Insurance Co Buys 25,267 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Advantage Alpha Capital Partners LP Sells 62,257 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Published on: 2025-11-29 10:13:00 - moha.gov.vn
What analysts say about ADMA Biologics Inc stockMarket Sentiment Report & No Fee. No Catch. Just Smart Investment Ideas - earlytimes.in
Ensign Peak Advisors Inc Acquires 80,462 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Adma Biologics Inc Stock (ADMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.67%
1.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):